Founded in 1921, Science News has established itself as a cornerstone of independent, nonprofit journalism, dedicated to delivering accurate and…
Read More
The Nanozymes Hypothesis Offers a Unified Framework for the Origin of Life on Earth
The enduring question of how life first arose on Earth, a cornerstone of scientific inquiry for centuries, has seen a…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
In a stark assessment of the current state of public health in the United States, Dr. Daniel Griffin, a seasoned…
Read More
Stanford University Study Reveals Gerozyme Inhibitor Capable of Regenerating Damaged Knee Cartilage and Halting Osteoarthritis Progression
A groundbreaking study led by researchers at Stanford Medicine has identified a therapeutic pathway that restores lost knee cartilage in…
Read More
Genetic Mutations Shared by Cancer and Blood Cells Identified as Potential Drivers of Alzheimer’s Disease Pathogenesis
Recent breakthroughs in genomic sequencing have fundamentally altered our understanding of how the human body ages, revealing that the genetic…
Read More
These tiny holes could change how the world cleans water
A collaborative group of scientists from the CSIR-Central Salt and Marine Chemicals Research Institute (CSMCRI), the Indian Institute of Technology…
Read More
LG AI Research and D&D Pharmatech Forge Landmark Partnership to Revolutionize Oral Peptide Drug Delivery Through Artificial Intelligence
LG AI Research and D&D Pharmatech have officially inked a pivotal agreement, signaling a new era in pharmaceutical innovation with…
Read More
Recreating Legendary Sea Silk: South Korean Researchers Unlock Ancient Fiber’s Golden Secret and Sustainable Future
For millennia, a fabric whispered about in tales of opulence and power, known as sea silk, captivated the world. Revered…
Read More
TWiV 1293: The enemy of your parasite is your friend
On February 1, 2026, the podcast "This Week in Virology" (TWiV) released its 1293rd episode, delving into two significant scientific…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
Johnson & Johnson is intensifying its efforts to expand the market footprint of Spravato (esketamine) for treatment-resistant depression (TRD), leveraging…
Read MoreYOU MAY HAVE MISSED
